Get started
Author

Matthew Boron

Observed names: M. Boron, Matthew J Boron, Matthew J. Boron
OpenAlex ID: A5061982886
Phase II Multicenter Trial of Bevacizumab Plus Fluorouracil and Leucovorin in Patients With Advanced Refractory Colorectal Cancer: An NCI Treatment Referral Center Trial TRC-0301
2006 · Helen X. Chen, Margaret Mooney, et al. · Journal of Clinical Oncology · 186
Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome
2010 · Brigitte C. Widemann, Frank M. Balis, et al. · Journal of Clinical Oncology · 167
PDF
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group
2023 · Steven G. DuBois, Mark D. Krailo, et al. · Journal of Clinical Oncology · 91
PDF
Treatment of Accidental Intrathecal Methotrexate Overdose With Intrathecal Carboxypeptidase G2
2004 · B. C. Widemann, F. M. Balis, et al. · JNCI Journal of the National Cancer Institute · 70
Carboxypeptidase-G2 (CPDG2) and leucovorin (LV) rescue with and without addition of thymidine (Thd) for high-dose methotrexate (HDMTX) induced renal dysfunction
2005 · P. C. Adamson, F. M. Balis, et al. · Journal of Clinical Oncology · 3
NCI’s national treatment trial networks: Experience and adaptations during COVID-19.
2021 · Margaret M. Mooney, Grace E. Mishkin, et al. · Journal of Clinical Oncology · 1
Expanded access trial of tocilizumab in COVID19+hospitalized cancer patients
2020 · Nirali N. Shah, Percy Ivy, et al. · Clinical Cancer Research · 1
P3.01.19 Gender Differences in Lung Cancer Diagnosis, Treatment Patterns and Outcomes: A Systematic Literature Review
2025 · N.F. Abdel Karim, C. Aggarwal, et al. · Journal of Thoracic Oncology
Perspective: The COVID-19 Pandemic: Closing Borders, Opening Doors, and Breaking Ground on the Potential for Clinical Trial Access in Developing Countries Like Trinidad and Tobago
2024 · Kellie Alleyne-Mike, John Glod, et al. · JCO Global Oncology
Abstract PO-092: Expanded access trial of tocilizumab in COVID19+ hospitalized cancer patients
2020 · Nirali N. Shah, Percy Ivy, et al. · Clinical Cancer Research
Early Access to Investigational Agents through the National Cancer Institute's Treatment Referral Center.
2012 · Tali M Johnson, Matthew J Boron · PubMed
Works count: 11
Citation count: 519
H-index: 4
I10-index: 4
Year
Topic
Type